+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Patient Simulator Market Size, Share & Industry Trends Analysis Report By Type, By End User, By Technology (Low-fidelity Simulators, Medium-fidelity Simulators, and High-fidelity Simulators), By Country and Growth Forecast, 2023 - 2029

  • PDF Icon

    Report

  • 81 Pages
  • May 2023
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5833911
The Asia Pacific Patient Simulator Market should witness market growth of 9.0% CAGR during the forecast period (2023-2029).

Due to increased overall healthcare spending, the market has been exhibiting signs of significant expansion. As the healthcare business continues to expand, more attention is being paid to enhancing the quality of treatment provided and decreasing the number of patients affected by medical mistakes. Because of this, there has been a rise in demand for effective and cutting-edge solutions to the problem of training experts, like patient simulators.

Due to the widespread incidence of cardiovascular diseases (CVDs) throughout the region, the rate of adoption of the cardiac simulator in hospitals and research centres is steadily increasing as the number of surgical and other treatment procedures increases. Additionally, cardiac simulation has become a practical addition to surgical education and training for the majority of specialties; as a result, it is projected that the studied market will grow throughout the forecast period due to the prevalence of CVDs.

The Indian government has established FDI-friendly policies and has implemented extensive structural and ongoing changes to enhance the healthcare sector. The "Aatmanirbhar Bharat Abhiyaan" packages include several immediate and long-term health systems improvements, such as Production-Linked Incentive (PLI) programs to increase domestic production of pharmaceuticals and medical equipment.

The healthcare system in India is being driven by the rising prevalence of lifestyle diseases, the demand for affordable healthcare delivery systems due to rising healthcare costs, technological advancements, the emergence of telemedicine, the rapid uptake of health insurance, government initiatives like e-health, as well as tax benefits and incentives. In addition, the expanding healthcare industry in the region will offer prospects for the patient simulator to thrive for improving healthcare training which will assist in the expansion of the market.

The China market dominated the Asia Pacific Patient Simulator Market by Country in 2022 thereby, achieving a market value of $71.5 Million by 2029. The Japan market is registering a CAGR of 8.4% during (2023-2029). Additionally, The India market would showcase a CAGR of 9.7% during (2023-2029).

Based on Type, the market is segmented into Adult Patient Simulator, Infant Simulator, and Childbirth Simulator. Based on End-user, the market is segmented into Hospitals, and Academic Institutions. Based on Technology, the market is segmented into Low-fidelity Simulators, Medium-fidelity Simulators, and High-fidelity Simulators. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Laerdal Medical Limited, CAE Inc., Gaumard Scientific Company, Inc., Kyoto Kagaku Co., Ltd., Medical-X, K.K. MedVision, Simulab Corporation, Limbs & Things Limited, Surgical Science Sweden AB, and Mentice AB.

Scope of the Study

By Type

  • Adult Patient Simulator
  • Infant Simulator
  • Childbirth Simulator

By End-user

  • Hospitals
  • Academic Institutions

By Technology

  • Low-fidelity Simulators
  • Medium-fidelity Simulators
  • High-fidelity Simulators

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

  • Laerdal Medical Limited
  • CAE Inc.
  • Gaumard Scientific Company, Inc.
  • Kyoto Kagaku Co., Ltd.
  • Medical-X
  • K.K. MedVision
  • Simulab Corporation
  • Limbs & Things Limited
  • Surgical Science Sweden AB
  • Mentice AB

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Patient Simulator Market, by Type
1.4.2 Asia Pacific Patient Simulator Market, by End-user
1.4.3 Asia Pacific Patient Simulator Market, by Technology
1.4.4 Asia Pacific Patient Simulator Market, by Country
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Patient Simulator Market by Type
3.1 Asia Pacific Adult Patient Simulator Market by Country
3.2 Asia Pacific Infant Simulator Market by Country
3.3 Asia Pacific Childbirth Simulator Market by Country
Chapter 4. Asia Pacific Patient Simulator Market by End-user
4.1 Asia Pacific Hospitals Market by Country
4.2 Asia Pacific Academic Institutions Market by Country
Chapter 5. Asia Pacific Patient Simulator Market by Technology
5.1 Asia Pacific Low-fidelity Simulators Market by Country
5.2 Asia Pacific Medium-fidelity Simulators Market by Country
5.3 Asia Pacific High-fidelity Simulators Market by Country
Chapter 6. Asia Pacific Patient Simulator Market by Country
6.1 China Patient Simulator Market
6.1.1 China Patient Simulator Market by Type
6.1.2 China Patient Simulator Market by End-user
6.1.3 China Patient Simulator Market by Technology
6.2 Japan Patient Simulator Market
6.2.1 Japan Patient Simulator Market by Type
6.2.2 Japan Patient Simulator Market by End-user
6.2.3 Japan Patient Simulator Market by Technology
6.3 India Patient Simulator Market
6.3.1 India Patient Simulator Market by Type
6.3.2 India Patient Simulator Market by End-user
6.3.3 India Patient Simulator Market by Technology
6.4 South Korea Patient Simulator Market
6.4.1 South Korea Patient Simulator Market by Type
6.4.2 South Korea Patient Simulator Market by End-user
6.4.3 South Korea Patient Simulator Market by Technology
6.5 Singapore Patient Simulator Market
6.5.1 Singapore Patient Simulator Market by Type
6.5.2 Singapore Patient Simulator Market by End-user
6.5.3 Singapore Patient Simulator Market by Technology
6.6 Malaysia Patient Simulator Market
6.6.1 Malaysia Patient Simulator Market by Type
6.6.2 Malaysia Patient Simulator Market by End-user
6.6.3 Malaysia Patient Simulator Market by Technology
6.7 Rest of Asia Pacific Patient Simulator Market
6.7.1 Rest of Asia Pacific Patient Simulator Market by Type
6.7.2 Rest of Asia Pacific Patient Simulator Market by End-user
6.7.3 Rest of Asia Pacific Patient Simulator Market by Technology
Chapter 7. Company Profiles
7.1 Laerdal Medical Limited
7.1.1 Company Overview
7.1.2 Recent Strategies and Developments
7.1.2.1 Partnerships, Collaborations, and Agreements
7.1.2.2 Acquisition and Mergers
7.2 CAE Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent Strategies and Developments
7.2.5.1 Partnerships, Collaborations, and Agreements
7.2.5.2 Product Launches and Product Expansions
7.3 Gaumard Scientific Company, Inc.
7.3.1 Company Overview
7.3.2 Recent Strategies and Developments
7.3.2.1 Product Launches and Product Expansions
7.4 Kyoto Kagaku Co., Ltd.
7.4.1 Company Overview
7.5 Medical-X
7.5.1 Company Overview
7.6 K.K. MedVision
7.6.1 Company Overview
7.7 Simulab Corporation
7.7.1 Company Overview
7.8 Limbs & Things Limited
7.8.1 Company Overview
7.8.2 Recent Strategies and Developments
7.8.2.1 Partnerships, Collaborations, and Agreements
7.9 Surgical Science Sweden AB
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent Strategies and Developments
7.9.5.1 Partnerships, Collaborations, and Agreements
7.9.5.2 Acquisition and Mergers
7.10. Mentice AB
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses
7.10.5 Recent Strategies and Developments
7.10.5.1 Acquisition and Mergers

Companies Mentioned

  • Laerdal Medical Limited
  • CAE Inc.
  • Gaumard Scientific Company, Inc.
  • Kyoto Kagaku Co., Ltd.
  • Medical-X
  • K.K. MedVision
  • Simulab Corporation
  • Limbs & Things Limited
  • Surgical Science Sweden AB
  • Mentice AB

Methodology

Loading
LOADING...